SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-16-001287
Filing Date
2016-02-26
Accepted
2016-02-26 16:06:04
Documents
2
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LLCCORMORANT GLOBAL HEALTHCARE GP, LLC

Document Format Files

Seq Description Document Type Size
1 cormorant13g.htm SC 13G 88441
2 exhibit1.htm EX-1 6612
  Complete submission text file 0000929638-16-001287.txt   96761
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Subject) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-89403 | Film No.: 161461689
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 617-848-3429
Cormorant Global Healthcare Master Fund, LP (Filed by) CIK: 0001618442 (see all company filings)

IRS No.: 981101801 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G